ஐ.எஸ்.எஸ்.என்: 2572-0805
Shweta Naik and BR.Das
The new WHO guidelines in 2015 on initiation of early antiretroviral therapy (ART) and on pre-exposure prophylaxis for HIV mark the next stage in the fight to curb the epidemic of HIV-AIDS. With ART for all, the number of people eligible for ART rises significantly. Implementation of these guidelines in the high burden, low income countries are the stepping stone to achieving the UNAIDS target of eliminating the HIV-AIDS epidemic by 2030. Scaling up of programmatic capacities globally to diagnose, treat and monitor therapy for HIV-AIDS is the need of the hour. Drug resistance may arise as a further challenge to the efficacy of therapy with the expected upsurge in ART coverage.